Kalii Chloridum + Natrii Chloridum Kabi (Potassium Chloride, Sodium Chloride)

When infused, potassium chloride releases potassium ions that help restore normal membrane potential, supporting cardiac and muscular activity. Sodium chloride provides sodium and chloride ions, which maintain extracellular fluid volume and osmotic balance. Together they normalize plasma electrolyte concentrations, preventing cellular dysfunction caused by deficiencies.

The dose of Kalii Chloridum + Natrii Chloridum Kabi is individualized. A qualified prescriber determines the amount and infusion rate based on the patient’s serum electrolyte levels, clinical condition, renal function, and overall fluid balance. No standard dosing regimen is provided here.

Safety in pregnancy and lactation depends on the clinical situation. Electrolyte replacement may be necessary, but the prescriber must weigh potential benefits against risks. Potassium and sodium are essential nutrients, yet dosing should be carefully monitored. Consultation with a healthcare professional is required before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Kalii Chloridum + Natrii Chloridum Kabi combines both potassium and sodium chloride in a single IV bag, offering a convenient way to address dual electrolyte deficits. Some alternatives provide only one electrolyte or require separate bags, which may increase preparation time. The combined formulation can simplify dosing when both ions need replacement, but selection should follow clinical guidelines.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Ensure the container remains sealed until use, and inspect for any discoloration or particulate matter before administration.

It is administered intravenously by a qualified healthcare professional. The solution is infused through a suitable IV line, with the rate adjusted according to the patient’s electrolyte status and clinical protocol. Continuous monitoring of vital signs and serum electrolytes is recommended during infusion.

The most serious risks include rapid elevation of serum potassium leading to cardiac arrhythmias, severe hypernatremia causing neurological complications, and rare anaphylactic reactions. Close monitoring of cardiac rhythm and electrolyte levels is essential to detect and manage these potential complications promptly.

Patients with untreated severe hyperkalemia, uncontrolled hypernatremia, or known hypersensitivity to the product components should not receive it. Additionally, individuals with severe renal impairment require dose adjustment and close supervision, and the solution should be avoided unless a prescriber determines it is safe.